United States· US:71308-021_43ecba1a-fa95-40e0-a383-8f9cdb6ad6b6
OLINVYK
A oliceridine product containing oliceridine, registered in United States by Trevena, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLICERIDINE
- Manufacturer
- Trevena, Inc.
- Country
- United States (US)
- ATC code
- N02AX07
- ATC class
- Oliceridine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11713080211010 VIAL, SINGLE-DOSE in 1 CARTON (71308-021-10) / 2 mL in 1 VIAL, SINGLE-DOSE (71308-021-01)
- ndc1171308-021-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
334 interactions on record for oliceridine.
Graded by severity as the source publishes them — 91 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oliceridine · interactions on record
334 records
- 91 severe
- 241 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N02AX07
Oliceridine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c2142ca-c6a3-4d2b-9a84-e15acd87c2c7 GET /v1/drugs/3c2142ca-c6a3-4d2b-9a84-e15acd87c2c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "OLICERIDINE",
"productndc": "71308-021",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": "CII",
"strength_unit": "mg/2mL",
"application_number": "NDA210730",
"marketing_category": "NDA"
}See everything about oliceridine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.